Dr Ian Galea is a clinician scientist who is internationally recognised for his work on the blood-brain barrier and haemoglobin neurotoxicity. His group work at the interface of laboratory and clinical medicine, with expertise in scientific measurement in health and disease. Of special interest to dementia researchers is a high-throughput urine test to measure systemic inflammation and a refined imaging method to measure blood-brain barrier permeability of the human brain. He is principal investigator of a study collecting cerebrospinal fluid, serum, urine and brain tissue samples, for use in neurodegenerative disease research.
